In “the first in a series of conversations with officials at the Centers for Disease Control and Prevention (CDC) discussing the CDC’s role in global HIV and tuberculosis (TB) research and development,” the Center for Global Health Policy’s “Science Speaks” blog interviews Kayla Laserson, director of the Kenya Medical Research Institute (KEMRI)/CDC Field Research Station in Kisumu, Kenya. Laserson answers questions about her work with the CDC, the latest research projects underway at KEMRI/CDC, and progress in Kenya’s HIV response since she began working in Kisumu six years ago, among other topics (Mazzotta, 2/14).
Programs, Funding & Financing
Writing on the U.S. Global Leadership Coalition’s website, Sarah Sagely Klotz, executive director of Hamlin Fistula USA, reports on how private U.S. investments “are building maternal care capacity and producing tremendous results” in Ethiopia. “Unfortunately, around the globe women are often neglected and have very limited access to maternal care,” she writes, adding, “Through the generous investments made by many Americans, however, communities in developing countries are yielding substantial and lasting benefits” (2/14).
“President Barack Obama [on Monday] proposed a $3.8 trillion budget for fiscal 2013 that aims to slash the deficit by $4 trillion over 10 years,” the Associated Press reports, and provides an agency-by-agency breakdown of the proposed budget (2/13). “Making up just one percent of the U.S. Government’s overall budget, the Department of State/USAID budget totals $51.6 billion,” a U.S. Department of State fact sheet notes (2/13). “Overall, funding for the Global Health Initiative (GHI) is down in the FY 2013 request, with most of the reduction coming from HIV/AIDS bilateral amounts,” according to the Kaiser Family Foundation’s Policy Tracker. “Most other areas saw decreases as well, except for family planning and funding for the Global Fund to Fight AIDS, Tuberculosis and Malaria and the GAVI Alliance, which increased,” the resource adds. The budget plan proposes a total of approximately $8.5 billion for GHI, down more than $300 million from FY 2012, the resource notes, adding that $6.4 billion of that funding would go to PEPFAR, including about $4.5 billion for HIV and $224 million for tuberculosis. The Global Fund receives $1.65 billion in the request, according to the resource (2/13).
The Neglected Tropical Disease Control Program (NTD Control Program), funded by USAID and managed by Research Triangle Institute International (RTI International), has released an updated version of its NTD Funding Gap Analysis Tool (NTD-FGAT), which “helps users accurately estimate the costs and funding gaps of public health programs” and “is intended as a supplementary instrument to improve resource and strategic planning in an already existing national NTD plan,” according to the Global Network for NTDs’ “End the Neglect” blog (2/13).
In this post in the U.S. Department of State’s “Dipnote” blog, Ambassador Eric Goosby, the United States Global AIDS Coordinator, responds to President Obama’s fiscal year (FY) 2013 budget request, writing, “It demonstrates that the United States remains fully committed to the fight against global AIDS, and will meet the…
“The growing threat of nodding disease and increased pressure for action has spurred the Ugandan government to announce a $3 million (USD) plan to address the mystery illness,” Global Health Frontline News reports, adding, “Initial funds will be used to set up screening centers and treat those affected in Pader, Kitgum, and Lamwo districts in northern Uganda as early as this month.”
In this post in the ONE blog, Brooks Keene, policy adviser for CARE’s water team, “makes the argument that foreign aid should benefit the poor first and foremost,” noting, “As we approach World Water Day on March 22, CARE, [the Natural Resources Defense Council (NRDC)] and WaterAid have published a report card [.pdf] on how well” the Water for the Poor Act, passed by Congress in 2005, “has been implemented seven years down the line.” She writes, “In the absence of a strategy, USAID has gone ahead with water, sanitation and hygiene programs, but much of the effort and dollars have not gone to benefit the poor.” She concludes by recommending several steps USAID could take “to spur concerted targeting” (2/9).
Donor Fatigue, Funding Cutbacks Could Mean Another 50 Years Of AIDS Epidemic, UNAIDS Deputy Executive Director Says
“With enough money spent in the right way, the world could soon reduce new HIV infections to zero, but global apathy and the financial crisis mean it might take another 50 years to stop the AIDS epidemic, a U.N. expert has said,” AlertNet reports. “At a time when HIV/AIDS efforts face an unprecedented decline in funding, Paul De Lay, deputy executive director of UNAIDS …, called on developing states to take more responsibility for tackling HIV in their own countries rather than relying on international assistance,” the news service notes.
“Grand Challenges Canada [on Thursday] announced 15 grants valued in total at more than $1.5 million awarded to some of Canada’s most creative innovators from across the country in support of their work to improve global health conditions,” according to a press release from the Sandra Rotman Centre for Global Health, which hosts Grand Challenges (2/9). “The grants are meant to fund ideas such as a simply designed, inexpensive prosthetic leg and a test for pneumonia that can be done on a cellphone in poor countries with few resources,” CBC News notes (Dakin, 2/9). The press release lists the grantees, briefly describes their innovations and provides a link to access two-minute videos created by each grantee to explain his or her proposal (2/9).
In this post on the Center for Global Development’s (CGD) “Global Health Policy” blog, Amanda Glassman, director of global health policy and a research fellow at CGD, and Denizhan Duran, a research assistant in global health policy at CGD, describe a paper they wrote in which they try to determine “[w]hich donor provides the ‘best’ health aid, and why [this is] a relevant question.” They write, “To be honest, one working paper later, we still do not have a definite answer to either question,” but “we do know … that health aid is relevant: effective health aid has saved lives, and technologies like oral rehydration salts and vaccination are among the most efficient development interventions money can buy.” The authors say they “rank donors across four dimensions of aid effectiveness: maximizing efficiency, fostering institutions, reducing burden and transparency and learning,” and invite readers to explore their data.